EVH - Evolent Health Inc logo

Evolent Health Inc

EVH

Evolent Health offers specialty care management services focused on oncology, cardiology, and musculoskeletal markets in the U.S. Its integrated platform supports health plans with data analytics, risk management, and administrative services.

⚕️ Healthcare NYSE Listed 2015 $ USD
$1,000 invested 10 years ago →$207today

Score Overview

1 Year
Score
Net Growth5.52%
Net TrendGrew
Net Income Consistency—
Rev Growth11.77%
Rev TrendGrew
Revenue Consistency—
5 Years
Score4.7
Net Growth-11x
Net Trend60%
Net Income Consistency—
Rev Growth130.96%
Rev Trend80%
Revenue Consistency—
10 Years
Score
Net Growth-216.13%
Net Trend60%
Net Income Consistency
Rev Growth8x
Rev Trend80%
Revenue Consistency
All Time
Score
Net Growth-251.88%
Net Trend55%
Net Income Consistency
Rev Growth21x
Rev Trend82%
Revenue Consistency

Explore the 2021 public Archive ranking →

Where Evolent Health Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. EVH does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-23
$ 4.80—
1 Year2025-10-23
$ 7.50-36.00%
5 Years2021-10-22
$ 30.22-84.12%
10 Years2016-10-21
$ 23.23-79.34%
All Time2015-06-05
$ 18.86-74.55%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 2.09B-$ 504M$ 115M
2025$ 1.87B-$ 534M$ 151M
2024$ 2.55B-$ 61M$ 163M
2023$ 1.96B-$ 113M$ 192M
2022$ 1.35B-$ 19M$ 188M
2021$ 907M-$ 37M$ 266M
2020$ 924M-$ 334M$ 333M
2019$ 687M-$ 301M$ 102M
2018$ 627M-$ 52M$ 228M
2017$ 434M-$ 60M$ 238M
2016$ 254M-$ 159M$ 178M
IPO2015$ 96M$ 332M$ 155M
EVH - Evolent Health Inc logo

Evolent Health Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 924M to $ 1.87B and net income went from -$ 334M to -$ 534M. Revenue increased in 4 of those 5 years; net income in 3.

Across Evolent Health Inc's full reported history, from 2015 to 2025, revenue grew from $ 96M to $ 1.87B and net income went from $ 332M to -$ 534M. Revenue increased in 82% of the years measured; net income in 55%.

Evolent Health Inc currently holds a 5-year HDB Score of 4.7 out of 10. How the HDB Score is calculated.

Membership

Explore EVH with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,112 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year · Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies